For: | Lech G, Słotwiński R, Słodkowski M, Krasnodębski IW. Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances. World J Gastroenterol 2016; 22(5): 1745-1755 [PMID: 26855534 DOI: 10.3748/wjg.v22.i5.1745] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i5/1745.htm |
Number | Citing Articles |
1 |
Marija Gegovska, Marija Hiljadnikova-Bajro. Novel laboratory biomarkers in colorectal cancer management. Macedonian Pharmaceutical Bulletin 2022; 68(03): 333 doi: 10.33320/maced.pharm.bull.2022.68.03.160
|
2 |
Tayebe Shahbazi, Bita Bakhshi, Mohammad Sadegh Fazeli, Elahe Derakhshan-Nezhadc. Bacterial biomarkers: new aspects of colorectal tumors diagnosis: reality or fantasy. European Journal of Cancer Prevention 2023; 32(5): 485 doi: 10.1097/CEJ.0000000000000760
|
3 |
James P. Stewart, Susan Richman, Tim Maughan, Mark Lawler, Philip D. Dunne, Manuel Salto-Tellez. Standardising RNA profiling based biomarker application in cancer—The need for robust control of technical variables. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2017; 1868(1): 258 doi: 10.1016/j.bbcan.2017.05.005
|
4 |
Jingpeng Wang, Shuyuan Li, Gaofeng Zhang, Huihua Han. Sevoflurane inhibits malignant progression of colorectal cancer via hsa_circ_0000231-mediated miR-622. Journal of Biological Research-Thessaloniki 2021; 28(1) doi: 10.1186/s40709-021-00145-6
|
5 |
Xin Liu, Dandan Feng, Xueyun Huo, Xiaoqin Xiao, Zhenwen Chen. Association of intron microsatellite status and exon mutational profiles of TP53 in human colorectal cancer. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.8095
|
6 |
Enkui Zhang, Chengsheng Ding, Shuchun Li, Batuer Aikemu, Xueliang Zhou, Xiaodong Fan, Jing Sun, Xiao Yang, Minhua Zheng. Polyamine metabolism patterns characterized tumor microenvironment, prognosis, and response to immunotherapy in colorectal cancer. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-02892-z
|
7 |
Shaojun Yu, Weixing Dai, Senlin Zhao, Yongzhi Yang, Ye Xu, Jianwei Wang, Qun Deng, Jinghu He, Debing Shi. Function and mechanism of MCM8 in the development and progression of colorectal cancer. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04084-9
|
8 |
Kareena Moar, Anuja Pant, Vikas Saini, Pawan Kumar Maurya. Potential biomarkers in endometrial cancer: a narrative review. Biomarkers 2023; 28(4): 358 doi: 10.1080/1354750X.2023.2179114
|
9 |
Yang Liu, Feng-Jiao Zhang, Xi-Xi Zhao, Yuan Yang, Chun-Yi Liang, Li-Li Feng, Xiang-Bo Wan, Yi Ding, Yao-Wei Zhang. Development of a Joint Prediction Model Based on Both the Radiomics and Clinical Factors for Predicting the Tumor Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer. Cancer Management and Research 2021; : 3235 doi: 10.2147/CMAR.S295317
|
10 |
Harshali Patil, Shailaja Gada Saxena, Colin J. Barrow, Jagat R. Kanwar, Arnab Kapat, Rupinder K. Kanwar. Chasing the personalized medicine dream through biomarker validation in colorectal cancer. Drug Discovery Today 2017; 22(1): 111 doi: 10.1016/j.drudis.2016.09.022
|
11 |
Liu Peng, Xin Zhang, Man-Li Zhang, Tao Jiang, Peng-Jun Zhang. Diagnostic value of matrix metalloproteinases 2, 7 and 9 in urine for early detection of colorectal cancer. World Journal of Gastrointestinal Surgery 2023; 15(5): 931-939 doi: 10.4240/wjgs.v15.i5.931
|
12 |
Simone Famularo, Flavio Milana, Matteo Cimino, Fabio Procopio, Guido Costa, Jacopo Galvanin, Elisa Paoluzzi Tomada, Francesca Margherita Bunino, Angela Palmisano, Matteo Donadon, Guido Torzilli. Hepatectomy versus Chemotherapy for Resectable Colorectal Liver Metastases in Progression after Perioperative Chemotherapy: Expanding the Boundaries of the Curative Intent. Cancers 2023; 15(3): 783 doi: 10.3390/cancers15030783
|
13 |
Serdar Saridemir, Hikmet E Güven, Bülent Aksel, Lütfi Doğan. Serum AMDL DR-70 levels: a new concept in the diagnosis and follow-up of colorectal carcinoma. Biomarkers in Medicine 2020; 14(8): 621 doi: 10.2217/bmm-2020-0004
|
14 |
Javad Ranjbaran, Hossein Safarpour, Samira Nomiri, Tahmine Tavakoli, Zohreh Rezaei, Fatemeh Salmani, Pegah Larki, Elham Chamani. Experimental validation of in silico analysis estimated the reverse effect of upregulated hsa‐miR‐106a‐5p and hsa‐miR‐223‐3p on SLC4A4 gene expression in Iranian patients with colorectal adenocarcinoma by RT‐qPCR. Cancer Medicine 2023; 12(6): 7005 doi: 10.1002/cam4.5499
|
15 |
Rui Li, Ning Liu, Rui Liu, Xin Jin, Zheng Li. Calixarene: A Supramolecular Material for Treating Cancer. Current Drug Delivery 2024; 21(2): 184 doi: 10.2174/1567201820666230417084210
|
16 |
Pauline A. J. Mendelaar, Marcel Smid, Job van Riet, Lindsay Angus, Mariette Labots, Neeltje Steeghs, Mathijs P. Hendriks, Geert A. Cirkel, Johan M. van Rooijen, Albert J. Ten Tije, Martijn P. Lolkema, Edwin Cuppen, Stefan Sleijfer, John W. M. Martens, Saskia M. Wilting. Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features. Nature Communications 2021; 12(1) doi: 10.1038/s41467-020-20887-6
|
17 |
Jing-Quan Su, Pin-Yu Lai, Pei-Hsuan Hu, Je-Ming Hu, Pi-Kai Chang, Chao-Yang Chen, Jia-Jheng Wu, Yu-Jyun Lin, Chien-An Sun, Tsan Yang, Chih-Hsiung Hsu, Hua-Ching Lin, Yu-Ching Chou. Differential DNA methylation analysis of <i>SUMF2</i>, <i>ADAMTS5</i>, and <i>PXDN</i> provides novel insights into colorectal cancer prognosis prediction in Taiwan. World Journal of Gastroenterology 2022; 28(8): 825-839 doi: 10.3748/wjg.v28.i8.825
|
18 |
Pieter-Jan Cuyle, Hans Prenen. Current and future biomarkers in the treatment of colorectal cancer. Acta Clinica Belgica 2017; 72(2): 103 doi: 10.1080/17843286.2016.1262996
|
19 |
Olivia Cano-Garrido, Patricia Álamo, Laura Sánchez-García, Aïda Falgàs, Alejandro Sánchez-Chardi, Naroa Serna, Eloi Parladé, Ugutz Unzueta, Mònica Roldán, Eric Voltà-Durán, Isolda Casanova, Antonio Villaverde, Ramón Mangues, Esther Vázquez. Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4+ Cancers. Cancers 2021; 13(12): 2929 doi: 10.3390/cancers13122929
|
20 |
Xuefeng Gao, Junfeng Yin, Ying Yao, Xiangya Ding. hsa_circ_0001955 Promotes Colorectal Cancer Progression by Regulating miR-583/FGF21 Axis. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/4288474
|
21 |
Erin Elizabeth Edwards, Katherine Gayle Birmingham, Meghan Jeanne O’Melia, Jaeho Oh, Susan Napier Thomas. Fluorometric Quantification of Single-Cell Velocities to Investigate Cancer Metastasis. Cell Systems 2018; 7(5): 496 doi: 10.1016/j.cels.2018.10.005
|
22 |
Mariela Montaño-Samaniego, Diana M. Bravo-Estupiñan, Oscar Méndez-Guerrero, Ernesto Alarcón-Hernández, Miguel Ibáñez-Hernández. Strategies for Targeting Gene Therapy in Cancer Cells With Tumor-Specific Promoters. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.605380
|
23 |
Hemant Goyal, Syed A. A. Sherazi, Rupinder Mann, Zainab Gandhi, Abhilash Perisetti, Muhammad Aziz, Saurabh Chandan, Jonathan Kopel, Benjamin Tharian, Neil Sharma, Nirav Thosani. Scope of Artificial Intelligence in Gastrointestinal Oncology. Cancers 2021; 13(21): 5494 doi: 10.3390/cancers13215494
|
24 |
Valter Lombardi, Iv�n Carrera, Ram�n Cacabelos. In�vitro and in�vivo cytotoxic effect of AntiGan against tumor cells. Experimental and Therapeutic Medicine 2017; doi: 10.3892/etm.2017.5681
|
25 |
Feng Cui, Di Qu, Ruya Sun, Han Tao, Junru Si, Yuqing Xu. The Role of Circulating CD16+CD56+ Natural Killer Cells in the Screening, Diagnosis, and Staging of Colorectal Cancer before Initial Treatment. Disease Markers 2019; 2019: 1 doi: 10.1155/2019/7152183
|
26 |
Maria Guarnaccia, Rosario Iemmolo, Salvatore Petralia, Sabrina Conoci, Sebastiano Cavallaro. Miniaturized Real-Time PCR on a Q3 System for Rapid KRAS Genotyping. Sensors 2017; 17(4): 831 doi: 10.3390/s17040831
|
27 |
Qun Fang, Aijie Yang, Anshan Dong, Ligang Zhao. <p>circPDSS1 Stimulates the Development of Colorectal Cancer via Activating the Wnt/β-Catenin Signaling</p>. OncoTargets and Therapy 2020; : 6329 doi: 10.2147/OTT.S249853
|
28 |
Violetta Rosiek, Agnes Bocian-Jastrzębska, Beata Kos-Kudła. Selected Serum Biomarkers (Leptin, Chromogranin A, CA19-9, CEA) in Patients with Pancreatic Neuroendocrine Neoplasm and Associations with Metabolic Syndrome. Cancers 2023; 15(8): 2348 doi: 10.3390/cancers15082348
|
29 |
Alena Novakova-Jiresova, Katerina Kopeckova, Ludmila Boublikova, Renata Chloupkova, Bohuslav Melichar, Lubos Petruzelka, Jindrich Finek, Ondrej Fiala, Peter Grell, Stanislav Batko, Zdenek Linke, Igor Kiss, Jana Prausova, Tomas Buchler. <p>Regorafenib for Metastatic Colorectal Cancer: An Analysis of a Registry-Based Cohort of 555 Patients</p>. Cancer Management and Research 2020; : 5365 doi: 10.2147/CMAR.S255332
|
30 |
Fei Yan, Zhiquan Tu, Li Duan, Dexing Wang , Feng Lin. MicroRNA-383 suppresses cell proliferation and invasion in colorectal cancer by directly targeting paired box 6. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8682
|
31 |
Mahmoud Alrahawy, Saryia Javed, Haitham Atif, Kareem Elsanhoury, Kamel Mekhaeil, George Eskander. Microbiome and Colorectal Cancer Management. Cureus 2022; doi: 10.7759/cureus.30720
|
32 |
Jingquan Jia, Lauren Howard, Yingmiao Liu, Mark D. Starr, John C. Brady, Donna Niedzwiecki, John H. Strickler, Andrew B. Nixon. Cabozantinib with or without Panitumumab for RAS wild-type metastatic colorectal cancer: impact of MET amplification on clinical outcomes and circulating biomarkers. Cancer Chemotherapy and Pharmacology 2022; 89(3): 413 doi: 10.1007/s00280-022-04404-8
|
33 |
Cristina Almeida, Ana Luísa Teixeira, Francisca Dias, Vera Machado, Mariana Morais, Gabriela Martins, Carlos Palmeira, Maria Emília Sousa, Inês Godinho, Sílvia Batista, Bruno Costa-Silva, Rui Medeiros. Extracellular Vesicles Derived-LAT1 mRNA as a Powerful Inducer of Colorectal Cancer Aggressive Phenotype. Biology 2022; 11(1): 145 doi: 10.3390/biology11010145
|
34 |
Cheng-Zhi Huang, Yue Zhou, Qi-Song Tong, Qi-Jia Duan, Qing Zhang, Jin-Zhi Du, Xue-Qing Yao. Precision medicine-guided co-delivery of ASPN siRNA and oxaliplatin by nanoparticles to overcome chemoresistance of colorectal cancer. Biomaterials 2022; 290: 121827 doi: 10.1016/j.biomaterials.2022.121827
|
35 |
S. C. Faria, T. Sagebiel, M. Patnana, V. Cox, C. Viswanathan, C. Lall, A. Qayyum, P. R. Bhosale. Tumor markers: myths and facts unfolded. Abdominal Radiology 2019; 44(4): 1575 doi: 10.1007/s00261-018-1845-0
|
36 |
Carlos A. Castro-Rojas, Antonio R. Esparza-Mota, Francisco Hernandez-Cabrera, Viktor J. Romero-Diaz, Juan F. Gonzalez-Guerrero, Hector Maldonado-Garza, Irma S. Garcia-Gonzalez, Sergio Buenaventura-Cisneros, Josefina Y. Sanchez-Lopez, Rocio Ortiz-Lopez, Alberto Camacho-Morales, Oralia Barboza-Quintana, Augusto Rojas-Martinez. Thymidylate synthase gene variants as predictors of clinical response and toxicity to fluoropyrimidine-based chemotherapy for colorectal cancer. Drug Metabolism and Personalized Therapy 2017; 32(4) doi: 10.1515/dmpt-2017-0028
|
37 |
Sanjay Kisan Metkar, Koyeli Girigoswami. Diagnostic biosensors in medicine – A review. Biocatalysis and Agricultural Biotechnology 2019; 17: 271 doi: 10.1016/j.bcab.2018.11.029
|
38 |
Mohammad Reza Mohammad Hoseini Azar, Morteza Akbari, Halgurd Nadhim Mohammed, Milad Asadi, Dariush Shanehbandi, Mehdi Rezai, Venus Zafari, Saman Niknam, Rozita Tamjidifar, Saeed Tarzi, Farshad Mahdavi. Dysregulation of miR-27a and SMAD2 can be a reliable indicator in the prognosis and diagnosis of CRC as well as in response to chemotherapy drugs. Gene Reports 2020; 21: 100844 doi: 10.1016/j.genrep.2020.100844
|
39 |
Panagiotis Katrakazas, Aristotelis Ballas, Marco Anisetti, Ilias Spais. An Artificial Intelligence Outlook for Colorectal Cancer Screening. 2022 IEEE Eighth International Conference on Big Data Computing Service and Applications (BigDataService) 2022; : 66 doi: 10.1109/BigDataService55688.2022.00018
|
40 |
Abhijeet R. Patil, Ming-Ying Leung, Sourav Roy. Identification of Hub Genes in Different Stages of Colorectal Cancer through an Integrated Bioinformatics Approach. International Journal of Environmental Research and Public Health 2021; 18(11): 5564 doi: 10.3390/ijerph18115564
|
41 |
Minghao Li, Jianbin Zhuang, Di Kang, Yuzhuo Chen, Weiliang Song. Identification of circRNA circ-CSPP1 as a potent driver of colorectal cancer by directly targeting the miR-431/LASP1 axis. Open Life Sciences 2021; 16(1): 523 doi: 10.1515/biol-2021-0053
|
42 |
Min-Yi Lv, Wei Wang, Min-Er Zhong, Du Cai, Dejun Fan, Cheng-Hang Li, Wei-Bin Kou, Ze-Ping Huang, Xin Duan, Chuling Hu, Qiqi Zhu, Xiaosheng He, Feng Gao. DNA Repair–Related Gene Signature in Predicting Prognosis of Colorectal Cancer Patients. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.872238
|
43 |
Hong Lei, Shan Yan, Yin He, Ning Xu, Min Zhao, Chun Yu, Hong Li, Sai Kuang, Zhan Cui, Jing Fang. Ki67 testing in the clinical management of patients with non‑metastatic colorectal cancer: Detecting the optimal cut‑off value based on the Restricted Cubic Spline model. Oncology Letters 2022; 24(6) doi: 10.3892/ol.2022.13540
|
44 |
Noor Alrushaid, Firdos Alam Khan, Ebtesam Al-Suhaimi, Abdelhamid Elaissari. Progress and Perspectives in Colon Cancer Pathology, Diagnosis, and Treatments. Diseases 2023; 11(4): 148 doi: 10.3390/diseases11040148
|
45 |
Anita Chawla, Miranda Peeples, Nanxin Li, Rachel Anhorn, Jason Ryan, James Signorovitch. Real-world utilization of molecular diagnostic testing and matched drug therapies in the treatment of metastatic cancers. Journal of Medical Economics 2018; 21(6): 543 doi: 10.1080/13696998.2017.1423488
|
46 |
Yali Wang, Kun Zheng, Xiuqiong Chen, Rui Chen, Yanmei Zou. Bioinformatics analysis identifies COL1A1, THBS2 and SPP1 as potential predictors of patient prognosis and immunotherapy response in gastric cancer. Bioscience Reports 2021; 41(1) doi: 10.1042/BSR20202564
|
47 |
Pratul Dipta Somadder, Md Arju Hossain, Asif Ahsan, Tayeba Sultana, Sadat Hossain Soikot, Md Masuder Rahman, Sobhy M. Ibrahim, Kawsar Ahmed, Francis M. Bui. Drug Repurposing and Systems Biology approaches of Enzastaurin can target potential biomarkers and critical pathways in Colorectal Cancer. Computers in Biology and Medicine 2023; 155: 106630 doi: 10.1016/j.compbiomed.2023.106630
|
48 |
Ran Zhao, Dongge Xia, Yingwei Chen, Zhentian Kai, Fangying Ruan, Chaoran Xia, Jingkai Gong, Jun Wu, Xueliang Wang. Improved diagnosis of colorectal cancer using combined biomarkers including Fusobacterium nucleatum, fecal occult blood, transferrin, CEA, CA19‐9, gender, and age. Cancer Medicine 2023; 12(13): 14636 doi: 10.1002/cam4.6067
|
49 |
Yan Zhang, Sheng Zheng, Nansheng Liao, Huifeng Huang, Wenxiao Chen, Zhenxing Wu, Deqing Wu. CircCTNNA1 acts as a ceRNA for miR-363-3p to facilitate the progression of colorectal cancer by promoting CXCL5 expression. Journal of Biological Research-Thessaloniki 2021; 28(1) doi: 10.1186/s40709-021-00135-8
|
50 |
Rong Mu Xia, Tao Liu, Wen Gang Li, Xiu Qin Xu. RNA‐binding protein RBM24 represses colorectal tumourigenesis by stabilising PTEN mRNA. Clinical and Translational Medicine 2021; 11(10) doi: 10.1002/ctm2.383
|
51 |
Peili Zhang, Zhigui Zuo, Aihua Wu, Wenjing Shang, Ruichun Bi, Qike Jin, Jianbo Wu, Lei Jiang. miR-600 inhibits cell proliferation, migration and invasion by targeting p53 in mutant p53-expressing human colorectal cancer cell lines. Oncology Letters 2017; 13(3): 1789 doi: 10.3892/ol.2017.5654
|
52 |
Markus K. Diener, Stefan Fichtner‐Feigl. Biomarkers in colorectal liver metastases: Rising complexity and unknown clinical significance?. Annals of Gastroenterological Surgery 2021; 5(4): 477 doi: 10.1002/ags3.12454
|
53 |
Lingxue Tang, Sheng Yu, Qianqian Zhang, Yinlian Cai, Wen Li, Senbang Yao, Huaidong Cheng. Identification of hub genes related to CD4+ memory T cell infiltration with gene co-expression network predicts prognosis and immunotherapy effect in colon adenocarcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.915282
|
54 |
Hong Woo Choi, Heyjin Kim, Ae-chin Oh, Jin Kyung Lee, Young Jun Hong. Diagnostic Significance of the Ratio of Plasma CYFRA 21-1 Autoantibody Immune Complex to Free CYFRA 21-1 in Patients with Colon Cancer. Journal of Laboratory Medicine and Quality Assurance 2020; 42(4): 218 doi: 10.15263/jlmqa.2020.42.4.218
|
55 |
Nayeralsadat Fatemi, Sascha Tierling, Hamidreza Aboulkheyr Es, Maryam Varkiani, Ehsan Nazemalhosseini Mojarad, Hamid Asadzadeh Aghdaei, Jörn Walter, Mehdi Totonchi. DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicine. International Journal of Cancer 2022; 151(12): 2068 doi: 10.1002/ijc.34186
|
56 |
Amjad Alharbi, Haifa Bin Dokhi, Ghadir Almuhaini, Futoon Alomran, Emad Masuadi, Nouf Alomran, Amanda Ewart Toland. Prevalence of colorectal cancer biomarkers and their impact on clinical outcomes in Riyadh, Saudi Arabia. PLOS ONE 2021; 16(5): e0249590 doi: 10.1371/journal.pone.0249590
|
57 |
Thomas Lawler, Lisa Parlato, Shaneda Warren Andersen. Racial disparities in colorectal cancer clinicopathological and molecular tumor characteristics: a systematic review. Cancer Causes & Control 2023; doi: 10.1007/s10552-023-01783-y
|
58 |
Kulyada Eurboonyanun, Rita Maria Lahoud, Hamed Kordbacheh, Ali Pourvaziri, Julaluck Promsorn, Payia Chadbunchachai, Aileen O’Shea, Isha D. Atre, Mukesh Harisinghani. Imaging predictors of BRAF mutation in colorectal cancer. Abdominal Radiology 2020; 45(8): 2336 doi: 10.1007/s00261-020-02484-9
|
59 |
Yihang Yuan, Ji Chen, Jue Wang, Ming Xu, Yunpeng Zhang, Peng Sun, Leilei Liang. Identification Hub Genes in Colorectal Cancer by Integrating Weighted Gene Co-Expression Network Analysis and Clinical Validation in vivo and vitro. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00638
|
60 |
Dongmei Zhao, Yanying Ma, Xu Li, Xiaoyu Lu. microRNA‐211 promotes invasion and migration of colorectal cancer cells by targeting FABP4 via PPARγ. Journal of Cellular Physiology 2019; 234(9): 15429 doi: 10.1002/jcp.28190
|
61 |
Satoru Monzen, Tatsuya Ueno, Mitsuru Chiba, Yuki Morino, Yasushi Mariya, Andrzej Wojcik, Lovisa Lundholm. Dose‑dependent expression of extracellular microRNAs in HCT116 colorectal cancer cells exposed to high‑dose‑rate ionising radiation. Molecular and Clinical Oncology 2021; 16(1) doi: 10.3892/mco.2021.2452
|
62 |
Shuang Guo, Kong‐xi Zhu, Wei‐hua Yu, Teng Wang, Shuai Li, Yun‐xia Wang, Chen‐chen Zhang, Jian‐qiang Guo. SH3PXD2A‐AS1/miR‐330‐5p/UBA2 ceRNA network mediates the progression of colorectal cancer through regulating the activity of the Wnt/β‐catenin signaling pathway. Environmental Toxicology 2021; 36(10): 1969 doi: 10.1002/tox.23038
|
63 |
Lula Smith, Samuel Anti, Natalie White, Sabita N. Saldanha. Epigenetic Mechanisms in Cancer. 2018; : 87 doi: 10.1016/B978-0-12-809552-2.00004-8
|
64 |
Chun Dai, Kun Wang, Ming Tan, Zhaolai Hua, Lin Xia, Lei Qin. A LoC-SERS platform based on triple signal amplification for highly sensitive detection of colorectal cancer miRNAs. Analytical Methods 2023; 15(33): 4194 doi: 10.1039/D3AY01006F
|
65 |
Yahang Liang, Jingbo Shi, Qingsi He, Guorui Sun, Lei Gao, Jianhong Ye, Xiaolong Tang, Hui Qu. Hsa_circ_0026416 promotes proliferation and migration in colorectal cancer via miR-346/NFIB axis. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01593-1
|
66 |
Milan Dastych, Frantisek Hubatka, Pavlina Turanek-Knotigova, Josef Masek, Radek Kroupa, Milan Raška, Jaroslav Turanek, Lubomir Prochazka. Overexpression of CD44v8-10 in Colon Polyps—A Possible Key to Early Diagnosis. Pathology and Oncology Research 2021; 27 doi: 10.3389/pore.2021.614281
|
67 |
Spyridon Christodoulou, Katerina Katsaraki, Panteleimon Vassiliu, Nikolaos Danias, Nikolaos Michalopoulos, Georgios Tzikos, Diamantis C. Sideris, Nikolaos Arkadopoulos. High Intratumoral i-tRF-GlyGCC Expression Predicts Short-Term Relapse and Poor Overall Survival of Colorectal Cancer Patients, Independent of the TNM Stage. Biomedicines 2023; 11(7): 1945 doi: 10.3390/biomedicines11071945
|
68 |
Li Deng, Geng-Ming Niu, Jun Ren, Chong-Wei Ke, Luis Loura. Identification of ATP8B1 as a Tumor Suppressor Gene for Colorectal Cancer and Its Involvement in Phospholipid Homeostasis. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/2015648
|
69 |
Xueting Liu, Litao Huang, Menghan Liu, Zhu Wang. The Molecular Associations of Signet-Ring Cell Carcinoma in Colorectum: Meta-Analysis and System Review. Medicina 2022; 58(7): 836 doi: 10.3390/medicina58070836
|
70 |
Yu Cao, Sergey K. Efetov, Mingze He, Yu Fu, Narasimha M. Beeraka, Jin Zhang, Xinliang Zhang, Namitha Bannimath, Kuo Chen. Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal Cancer and Invasive Breast Cancer. Archivum Immunologiae et Therapiae Experimentalis 2023; 71(1) doi: 10.1007/s00005-023-00684-x
|
71 |
Non-steroidal anti-inflammatory drugs and biomarkers: A new paradigm in colorectal cancer. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1130710
|
72 |
Shazana Hilda Shamsuddin, David G. Jayne, Darren C. Tomlinson, Michael J. McPherson, Paul A. Millner. Selection and characterisation of Affimers specific for CEA recognition. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-020-80354-6
|
73 |
Yan Dang, Shutian Zhang, Yongjun Wang, Guiping Zhao, Chuyan Chen, Wei Jiang. State-of-the-Art: Exosomes in Colorectal Cancer. Current Cancer Drug Targets 2022; 22(1): 2 doi: 10.2174/1568009621666211110094442
|
74 |
Yan Cheng, Jing Wu, Bin Qin, Bai-cang Zou, Yong-hua Wang, Yang Li. CREB1-induced lncRNA LEF1-AS1 contributes to colorectal cancer progression via the miR-489/DIAPH1 axis. Biochemical and Biophysical Research Communications 2020; 526(3): 678 doi: 10.1016/j.bbrc.2020.03.153
|
75 |
Jiaan Kuang, Yizhen Gong, Hailun Xie, Ling Yan, Shizhen Huang, Feng Gao, Shuangyi Tang, Jialiang Gan. The prognostic value of preoperative serum CA724 for CEA-normal colorectal cancer patients. PeerJ 2020; 8: e8936 doi: 10.7717/peerj.8936
|
76 |
Hendra Susanto, Ahmad Taufiq, Dwi Listyorini, Adeodatus Yuda Handaya, Melati Putri Pertiwi. Protein-Based Biomaterial Marker in Metabolic Syndrome and Colorectal Cancer: A Preliminary Clinical Study of Betatrophin Expression in Javanese Ethnic. IOP Conference Series: Materials Science and Engineering 2019; 515: 012054 doi: 10.1088/1757-899X/515/1/012054
|
77 |
Yichao Liang, Xin Wu, Qi Su, Yujie Liu, Hong Xiao. Identification and Validation of a Novel Inflammatory Response-Related Gene Signature for the Prognosis of Colon Cancer. Journal of Inflammation Research 2021; : 3809 doi: 10.2147/JIR.S321852
|
78 |
Chunhui Jiang, Ye Liu, Siyuan Wen, Chunjie Xu, Lei Gu. In silico development and clinical validation of novel 8 gene signature based on lipid metabolism related genes in colon adenocarcinoma. Pharmacological Research 2021; 169: 105644 doi: 10.1016/j.phrs.2021.105644
|
79 |
Caihong Wen, Xiaoqing Feng, Honggang Yuan, Yong Gong, Guangsheng Wang. Circ_0003266 sponges miR-503-5p to suppress colorectal cancer progression via regulating PDCD4 expression. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-07997-0
|
80 |
Tao Lv, Lijun Shen, Xiaoya Xu, Ye Yao, Peiyuan Mu, Hui Zhang, Juefeng Wan, Yan Wang, Ruoyu Guan, Xiaomeng Li, Guoxiang Fu, Long Zhang, Yaqi Wang, Fan Xia, Chen Hu, Hans Clevers, Zhen Zhang, Guoqiang Hua. Patient‐derived tumor organoids predict responses to irinotecan‐based neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer. International Journal of Cancer 2023; 152(3): 524 doi: 10.1002/ijc.34302
|
81 |
Liangliang Liao, Yongjian Gao, Jie Su, Ye Feng. By characterizing metabolic and immune microenvironment reveal potential prognostic markers in the development of colorectal cancer. Frontiers in Bioengineering and Biotechnology 2022; 10 doi: 10.3389/fbioe.2022.822835
|
82 |
Xiao-Shun He, Sheng-Yi Zou, Jia-Lu Yao, Wangjianfei Yu, Zhi-Yong Deng, Jing-Ru Wang, Wen-Juan Gan, Shan Wan, Xiao-Qin Yang, Hua Wu. Transcriptomic Analysis Identifies Complement Component 3 as a Potential Predictive Biomarker for Chemotherapy Resistance in Colorectal Cancer. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.763652
|
83 |
Sang‐Min Park, Chae Young Hwang, Sung‐Hwan Cho, Daewon Lee, Jeong‐Ryeol Gong, Soobeom Lee, Sohee Nam, Kwang‐Hyun Cho. Systems analysis identifies potential target genes to overcome cetuximab resistance in colorectal cancer cells. The FEBS Journal 2019; 286(7): 1305 doi: 10.1111/febs.14773
|
84 |
Hae Yeon Kang, Eun Kyung Choe, Kyu Joo Park, Young Lee. Factors Requiring Adjustment in the Interpretation of Serum Carcinoembryonic Antigen: A Cross-Sectional Study of 18,131 Healthy Nonsmokers. Gastroenterology Research and Practice 2017; 2017: 1 doi: 10.1155/2017/9858931
|
85 |
D Ligi, F Mannello. Do matrix metalloproteinases represent reliable circulating biomarkers in colorectal cancer?. British Journal of Cancer 2016; 115(6): 633 doi: 10.1038/bjc.2016.241
|
86 |
Haili Wu, Jin’e Du, Chenglu Li, Hanqing Li, Huiqin Guo, Zhuoyu Li. Kaempferol Can Reverse the 5-Fu Resistance of Colorectal Cancer Cells by Inhibiting PKM2-Mediated Glycolysis. International Journal of Molecular Sciences 2022; 23(7): 3544 doi: 10.3390/ijms23073544
|
87 |
Cyndy Simonson. Predictive Biomarkers: Understanding Their Use in Treatment Decision Making. Clinical Journal of Oncology Nursing 2019; 23(4): 360 doi: 10.1188/19.CJON.360-363
|
88 |
Agnieszka Kalita, Magdalena Sikora-Skrabaka, Ewa Nowakowska-Zajdel. Role of Some microRNA/ADAM Proteins Axes in Gastrointestinal Cancers as a Novel Biomarkers and Potential Therapeutic Targets—A Review. Current Issues in Molecular Biology 2023; 45(4): 2917 doi: 10.3390/cimb45040191
|
89 |
Arthur T. Kopylov, Alexander A. Stepanov, Kristina A. Malsagova, Deepesh Soni, Nikolay E. Kushlinsky, Dmitry V. Enikeev, Natalia V. Potoldykova, Andrey V. Lisitsa, Anna L. Kaysheva. Revelation of Proteomic Indicators for Colorectal Cancer in Initial Stages of Development. Molecules 2020; 25(3): 619 doi: 10.3390/molecules25030619
|
90 |
Jinhua He, Feifeng Wu, Zeping Han, Min Hu, Weida Lin, Yuguang Li, Mingrong Cao. Biomarkers (mRNAs and Non-Coding RNAs) for the Diagnosis and Prognosis of Colorectal Cancer – From the Body Fluid to Tissue Level. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.632834
|
91 |
Lei Shen, Wei Zong, Wei Feng, Erlin Chen, Shuo Ma, Jie Yuan, Guihua Wang, Xinliang Gu, Xianjuan Shen, Shaoqing Ju. Upregulated Linc01836 in Serum Promisingly Serving as a Diagnostic and Prognostic Biomarker for Colorectal Cancer. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.840391
|
92 |
Tao Wang, Yihua Xu, Qicheng Chen, Weilin Zheng, Jie Wang, Haiping Zeng, Yuyan Wu, Lixing Cao, Zhiqiang Chen. Metabolomics Analysis of Laparoscopic Surgery Combined with Wuda Granule to Promote Rapid Recovery of Patients with Colorectal Cancer Using UPLC/Q-TOF-MS/MS. Evidence-Based Complementary and Alternative Medicine 2020; 2020: 1 doi: 10.1155/2020/5068268
|
93 |
Eunyoung Kim, Sohee Jung, Won Seo Park, Joon-Hyop Lee, Rumi Shin, Seung Chul Heo, Eun Kyung Choe, Jae Hyun Lee, Kwangsoo Kim, Young Jun Chai. Upregulation of SLC2A3 gene and prognosis in colorectal carcinoma: analysis of TCGA data. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5475-x
|
94 |
Ainaz Mihanfar, Bahman Yousefi, Saber Ghazizadeh Darband, Shirin Sadighparvar, Mojtaba Kaviani, Maryam Majidinia. Melatonin increases 5-flurouracil-mediated apoptosis of colorectal cancer cells through enhancing oxidative stress and downregulating survivin and XIAP. BioImpacts 2020; 11(4): 253 doi: 10.34172/bi.2021.36
|
95 |
Amin El-Heliebi, Ellen Heitzer. Nucleic Acid Nanotheranostics. 2019; : 133 doi: 10.1016/B978-0-12-814470-1.00005-8
|
96 |
Samantha Perakis, Martina Auer, Jelena Belic, Ellen Heitzer. . Advances in Clinical Chemistry 2017; 80: 73 doi: 10.1016/bs.acc.2016.11.005
|
97 |
Wolfgang Eberhardt, Kristina Haeussler, Usman Nasrullah, Josef Pfeilschifter. Multifaceted Roles of TRIM Proteins in Colorectal Carcinoma. International Journal of Molecular Sciences 2020; 21(20): 7532 doi: 10.3390/ijms21207532
|
98 |
Li Qi, Yue Yin, Mengqi Sun. LncRNA NCK1-AS1 Facilitates Colorectal Carcinoma Proliferation by Modulating the IGF1/AKT Signaling Pathway: A Detailed Study. Science of Advanced Materials 2023; 15(6): 856 doi: 10.1166/sam.2023.4491
|
99 |
Monika Zajkowska, Barbara Mroczko. Eotaxins and Their Receptor in Colorectal Cancer—A Literature Review. Cancers 2020; 12(6): 1383 doi: 10.3390/cancers12061383
|
100 |
Liliana A.A.N.A. Truta, Felismina T.C. Moreira, M. Goreti F. Sales. A dye-sensitized solar cell acting as the electrical reading box of an immunosensor: Application to CEA determination. Biosensors and Bioelectronics 2018; 107: 94 doi: 10.1016/j.bios.2018.02.011
|
101 |
Guang-yao Ye, Zi-zhen Zhang, Chun-chao Zhu, Zhi-jie Cong, Zhe Cui, Lu Chen, Gang Zhao. Long Non-Coding RNA LINC01569 Promotes Proliferation and Metastasis in Colorectal Cancer by miR-381-3p/RAP2A Axis. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.727698
|
102 |
José Luis García-Giménez, Marta Seco-Cervera, Trygve O. Tollefsbol, Carlos Romá-Mateo, Lorena Peiró-Chova, Pablo Lapunzina, Federico V. Pallardó. Epigenetic biomarkers: Current strategies and future challenges for their use in the clinical laboratory. Critical Reviews in Clinical Laboratory Sciences 2017; 54(7-8): 529 doi: 10.1080/10408363.2017.1410520
|
103 |
Oriane Dudez, Véronique Dalstein, Lukshe Kanagaratnam, Saviz Nasri, Christelle Coquelet, Caroline Fichel, Nicole Bouland, Emeric Lemaire, Marie-Danièle Diebold, Aude Marchal-Bressenot, Camille Boulagnon-Rombi. Is the Mirror Image Method Really Useful in Tumor Tissue Bank Quality Control?. Biopreservation and Biobanking 2019; 17(6): 539 doi: 10.1089/bio.2018.0123
|
104 |
Guoliang Mao, Bing Zhou, Wuqin Xu, Nanlin Jiao, Zhihao Wu, Jiajia Li, Yinhua Liu. Hsa_circ_0040809 regulates colorectal cancer development by upregulating methyltransferase DNMT1 via targeting miR‐515‐5p. The Journal of Gene Medicine 2021; 23(12) doi: 10.1002/jgm.3388
|
105 |
Humberto Nicolini, Alma Delia Genis-Mendoza, José Jaime Martínez-Magaña. Principles of Genetics and Molecular Epidemiology. 2022; : 45 doi: 10.1007/978-3-030-89601-0_4
|
106 |
Guo Wu, Jun-Gang Liu, Xiao-Liang Huang, Chun-Yin Wei, Franco Jeen PC, Wei-Shun Xie, Shao-Mei Chen, Chu-Qiao Zhang, Wei-Zhong Tang. A nomogram for preoperative prediction of lymphatic infiltration in colorectal cancer. Medicine 2019; 98(52): e18498 doi: 10.1097/MD.0000000000018498
|
107 |
Dominika Dakowicz, Monika Zajkowska, Barbara Mroczko. Relationship between VEGF Family Members, Their Receptors and Cell Death in the Neoplastic Transformation of Colorectal Cancer. International Journal of Molecular Sciences 2022; 23(6): 3375 doi: 10.3390/ijms23063375
|
108 |
Valentine N. Nfonsam, Hunter Jecius, Debbie Chen, Pamela N. Omesiete, Agnes N. Ewongwo, Emad Elquza, Aaron J. Scott, Jana Jandova. Increasing Incidence of Colon Cancer in the Young: Assessing the Tumor Biology. Journal of the American College of Surgeons 2019; 229(1): 79 doi: 10.1016/j.jamcollsurg.2019.03.022
|
109 |
Eva Breuer, Monika Hebeisen, Marcel André Schneider, Lilian Roth, Chantal Pauli, Katharina Frischer-Ordu, Janina Eden, Basile Pache, Thomas Steffen, Martin Hübner, Laurent Villeneuve, Vahan Kepenekian, Guillaume Passot, Philippe Gertsch, Anurag Gupta, Olivier Glehen, Kuno Lehmann. Site of Recurrence and Survival After Surgery for Colorectal Peritoneal Metastasis. JNCI: Journal of the National Cancer Institute 2021; 113(8): 1027 doi: 10.1093/jnci/djab001
|
110 |
Spyridon Christodoulou, Christina D. Sotiropoulou, Panteleimon Vassiliu, Nikolaos Danias, Nikolaos Arkadopoulos, Diamantis C. Sideris. MicroRNA-675-5p Overexpression Is an Independent Prognostic Molecular Biomarker of Short-Term Relapse and Poor Overall Survival in Colorectal Cancer. International Journal of Molecular Sciences 2023; 24(12): 9990 doi: 10.3390/ijms24129990
|
111 |
Wei Wang, Lijiang Zhou, Zheng Li, Guanhong Lin. Circ_0014130 is involved in the drug sensitivity of colorectal cancer through miR‐197‐3p/PFKFB3 axis. Journal of Gastroenterology and Hepatology 2022; 37(5): 908 doi: 10.1111/jgh.15829
|
112 |
Qian Zhou, Lin-Ling Ju, Xiang Ji, Ya-Li Cao, Jian-Guo Shao, Lin Chen. Plasma circRNAs as Biomarkers in Cancer. Cancer Management and Research 2021; : 7325 doi: 10.2147/CMAR.S330228
|
113 |
Xi Chen, Jiwu Song, Xiaoxiao Wang, Dongyuan Sun, Yunxia Liu, Yingying Jiang. LncRNA LINC00460: Function and mechanism in human cancer. Thoracic Cancer 2022; 13(1): 3 doi: 10.1111/1759-7714.14238
|
114 |
Haiping Li, Zhikun Zhang, Lu Gan, Dianfa Fan, Xinjun Sun, Zhangbo Qian, Xiyu Liu, Yong Huang. Signal Amplification-Based Biosensors and Application in RNA Tumor Markers. Sensors 2023; 23(9): 4237 doi: 10.3390/s23094237
|
115 |
C. Lino, S. Barrias, R. Chaves, F. Adega, P. Martins-Lopes, J.R. Fernandes. Biosensors as diagnostic tools in clinical applications. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(3): 188726 doi: 10.1016/j.bbcan.2022.188726
|
116 |
Ludovic Barault, Alessio Amatu, Giulia Siravegna, Agostino Ponzetti, Sebastian Moran, Andrea Cassingena, Benedetta Mussolin, Chiara Falcomatà, Alexandra M Binder, Carmen Cristiano, Daniele Oddo, Simonetta Guarrera, Carlotta Cancelliere, Sara Bustreo, Katia Bencardino, Sean Maden, Alice Vanzati, Patrizia Zavattari, Giuseppe Matullo, Mauro Truini, William M Grady, Patrizia Racca, Karin B Michels, Salvatore Siena, Manel Esteller, Alberto Bardelli, Andrea Sartore-Bianchi, Federica Di Nicolantonio. Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer. Gut 2018; 67(11): 1995 doi: 10.1136/gutjnl-2016-313372
|
117 |
Jie Meng, Rui Su, Yun Liao, Yanyan Li, Ling Li. Identification of 10 Hub genes related to the progression of colorectal cancer by co-expression analysis. PeerJ 2020; 8: e9633 doi: 10.7717/peerj.9633
|
118 |
Niloofar Asadi Hanjani, Nazanin Esmaelizad, Saba Zanganeh, Abdulwahab Teflischi Gharavi, Pegah Heidarizadeh, Maryam Radfar, Fateme Omidi, Ronan MacLoughlin, Mohammad Doroudian. Emerging role of exosomes as biomarkers in cancer treatment and diagnosis. Critical Reviews in Oncology/Hematology 2022; 169: 103565 doi: 10.1016/j.critrevonc.2021.103565
|
119 |
Chao Wang, Sheng-Qiang Li, Yan Zhao. Effects of different administration strategies of cetuximab on remission rate, MMPs, miR-106b-5p, PCAT-1, and adverse reactions in patients with RAS wild-type CRC liver metastasis. World Chinese Journal of Digestology 2022; 30(4): 204 doi: 10.11569/wcjd.v30.i4.204
|
120 |
Zhaoyan Qiu, Qian Li, Yixun Lu, Qian Wang. Clinical significance and prognostic value of circulating B10 cells in colorectal cancer. Asia-Pacific Journal of Clinical Oncology 2022; 18(2) doi: 10.1111/ajco.13586
|
121 |
Mohammed Alghamdi, Nujud Alabdullatif, Ajeed Al-Rashoud , Joud Alotaibi , Nouf Alhussaini , Sedra Elsirawani , Haneen Somily , Norah Alkhudair, Maram AlOtaiby, Shaik S Ahamed, Nashwa Abd El-Aziz. KRAS Mutations in Colorectal Cancer: Relationship With Clinicopathological Characteristics and Impact on Clinical Outcomes in Saudi Arabia. Cureus 2022; doi: 10.7759/cureus.23656
|
122 |
Bo Zhang, Wenbin Cao, Yang Liu, Yongkui Zhao, Chunhui Liu, Bingfu Sun. Circ_0056618 enhances PRRG4 expression by competitively binding to miR-411-5p to promote the malignant progression of colorectal cancer. Molecular and Cellular Biochemistry 2023; 478(3): 503 doi: 10.1007/s11010-022-04525-x
|
123 |
Constantin Stefani, Daniela Miricescu, Iulia-Ioana Stanescu-Spinu, Remus Iulian Nica, Maria Greabu, Alexandra Ripszky Totan, Mariana Jinga. Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?. International Journal of Molecular Sciences 2021; 22(19): 10260 doi: 10.3390/ijms221910260
|
124 |
Fabio Gelsomino, Monica Barbolini, Andrea Spallanzani, Giuseppe Pugliese, Stefano Cascinu. The evolving role of microsatellite instability in colorectal cancer: A review. Cancer Treatment Reviews 2016; 51: 19 doi: 10.1016/j.ctrv.2016.10.005
|
125 |
Bo HUANG, Xun ZHAO, Dejun CUI, Wenqiang YUAN, Liuchan YANG. Twist and Vimentin protein expression in colorectal cancer tissues and their relationship with oxaliplatin-based postoperative adjuvant chemotherapy. Panminerva Medica 2022; 64(4) doi: 10.23736/S0031-0808.21.04579-1
|
126 |
Katherine G. Birmingham, Meghan J. O'Melia, Dongjo Ban, Janna Mouw, Erin E. Edwards, Adam I. Marcus, John McDonald, Susan N. Thomas. Analyzing Mechanisms of Metastatic Cancer Cell Adhesive Phenotype Leveraging Preparative Adhesion Chromatography Microfluidic. Advanced Biosystems 2019; 3(3) doi: 10.1002/adbi.201800328
|
127 |
Yu-Xia Zhan, Guang-Hua Luo. DNA methylation detection methods used in colorectal cancer. World Journal of Clinical Cases 2019; 7(19): 2916-2929 doi: 10.12998/wjcc.v7.i19.2916
|
128 |
Kazuhisa Hosoya, Satoshi Matsusaka, Tomomi Kashiwada, Koichi Suzuki, Norio Ureshino, Akemi Sato, Yoshio Miki, Kazuki Kitera, Mitsuharu Hirai, Kiyohiko Hatake, Shinya Kimura, Naoko Sueoka-Aragane. Detection of KRAS Mutations in Plasma DNA Using a fully Automated Rapid Detection System in Colorectal Cancer Patients. Pathology & Oncology Research 2017; 23(4): 737 doi: 10.1007/s12253-016-0175-1
|
129 |
Michihiro Kudou, Toshiyuki Kosuga, Eigo Otsuji. Artificial intelligence in gastrointestinal cancer: Recent advances and future perspectives. Artificial Intelligence in Gastroenterology 2020; 1(4): 71-85 doi: 10.35712/aig.v1.i4.71
|
130 |
B. Weixler, F. Renetseder, I. Facile, N. Tosti, E. Cremonesi, A. Tampakis, T. Delko, S. Eppenberger-Castori, A. Tzankov, G. Iezzi, C. Kettelhack, S. D. Soysal, U. von Holzen, G. C. Spagnoli, L. Terracciano, L. Tornillo, Raoul A. Droeser, S. Däster. Phosphorylated CXCR4 expression has a positive prognostic impact in colorectal cancer. Cellular Oncology 2017; 40(6): 609 doi: 10.1007/s13402-017-0348-2
|
131 |
Claudia Burz, Vlad-Vasile Pop, Rares Buiga, Sur Daniel, Gabriel Samasca, Cornel Aldea, Iulia Lupan. Circulating tumor cells in clinical research and monitoring patients with colorectal cancer. Oncotarget 2018; 9(36): 24561 doi: 10.18632/oncotarget.25337
|
132 |
Razan M. Obeidat, Mariam M. Al-Omari, Nisreen M. Bataineh, Marwa M. Barukba, Mohammed A. Okour, Khaled M. Al-Qaoud. Production of Monoclonal antibodies to membrane components of human colorectal cancer HCT-116 cell line for diagnostic purposes. Arabian Journal of Chemistry 2023; 16(4): 104627 doi: 10.1016/j.arabjc.2023.104627
|
133 |
Linlin Cao, Sumei Lu, Chengjie Guo, Wenqiang Chen, Yinan Gao, Diwen Ye, Zejun Guo, Wanshan Ma. A novel electrochemical immunosensor based on PdAgPt/MoS2 for the ultrasensitive detection of CA 242. Frontiers in Bioengineering and Biotechnology 2022; 10 doi: 10.3389/fbioe.2022.986355
|
134 |
Xuezhong Liu, Qiuyuan Wang. Ras-Related Protein Rap1A Accelerates the Malignant Process of Colorectal Carcinoma via Activating Fibroblast Growth Factor-2. Journal of Biomedical Nanotechnology 2023; 19(7): 1301 doi: 10.1166/jbn.2023.3636
|
135 |
Chih-Hsiung Hsu, Cheng-Wen Hsiao, Chien-An Sun, Wen-Chih Wu, Tsan Yang, Je-Ming Hu, Chi-Hua Huang, Yu-Chan Liao, Chao-Yang Chen, Fu-Huang Lin, Yu-Ching Chou. Novel methylation gene panel in adjacent normal tissues predicts poor prognosis of colorectal cancer in Taiwan. World Journal of Gastroenterology 2020; 26(2): 154-167 doi: 10.3748/wjg.v26.i2.154
|
136 |
Xiaoyan Zhang, Wei Zhu, Junjie Lu. microRNA-133b Regulates Cell Proliferation and Cell Cycle Progression via Targeting HuR in Colorectal Cancer. Journal of Biomaterials and Tissue Engineering 2022; 12(2): 335 doi: 10.1166/jbt.2022.2910
|
137 |
Sonia Solanes-Casado, Arancha Cebrián, María Rodríguez-Remírez, Ignacio Mahíllo, Laura García-García, Anxo Río-Vilariño, Natalia Baños, Guillermo de Cárcer, Ana Monfort-Vengut, Víctor Castellano, Maria Jesús Fernández-Aceñero, Jesús García-Foncillas, Laura del Puerto-Nevado. Overcoming PLK1 inhibitor resistance by targeting mevalonate pathway to impair AXL-TWIST axis in colorectal cancer. Biomedicine & Pharmacotherapy 2021; 144: 112347 doi: 10.1016/j.biopha.2021.112347
|
138 |
Alvaro Gutierrez, Hannah Demond, Priscilla Brebi, Carmen Gloria Ili. Novel Methylation Biomarkers for Colorectal Cancer Prognosis. Biomolecules 2021; 11(11): 1722 doi: 10.3390/biom11111722
|
139 |
Vera S. Schellerer, Melanie C. Langheinrich, Veronika Zver, Robert Grützmann, Michael Stürzl, Olaf Gefeller, Elisabeth Naschberger, Susanne Merkel. Soluble intercellular adhesion molecule-1 is a prognostic marker in colorectal carcinoma. International Journal of Colorectal Disease 2019; 34(2): 309 doi: 10.1007/s00384-018-3198-0
|
140 |
Hsien-Cheng Huang, Bei-Hao Shiu, Shih-Chi Su, Chi-Chou Huang, Wen-Chien Ting, Lun-Ching Chang, Shun-Fa Yang, Ying-Erh Chou. The Impact of Matrix Metalloproteinase-11 Polymorphisms on Colorectal Cancer Progression and Clinicopathological Characteristics. Diagnostics 2022; 12(7): 1685 doi: 10.3390/diagnostics12071685
|
141 |
Floris A. Vuijk, Denise E. Hilling, J. Sven D. Mieog, Alexander L. Vahrmeijer. Fluorescent‐guided surgery for sentinel lymph node detection in gastric cancer and carcinoembryonic antigen targeted fluorescent‐guided surgery in colorectal and pancreatic cancer. Journal of Surgical Oncology 2018; 118(2): 315 doi: 10.1002/jso.25139
|
142 |
Mona Pourjafar, Pouria Samadi, Manoochehr Karami, Rezvan Najafi. Assessment of clinicopathological and prognostic relevance of BMI‐1 in patients with colorectal cancer: A meta‐analysis. Biotechnology and Applied Biochemistry 2020; doi: 10.1002/bab.2053
|
143 |
Lujia Dong, Di Liu, Dongshuai Jing, Huihui Xu, Chenxiao Zhang, Donglei Qi, Dechun Liu. LncRNA ARST is a Novel Prognostic and Diagnostic Biomarker for Colorectal Cancer. Cancer Management and Research 2022; : 19 doi: 10.2147/CMAR.S338997
|
144 |
Julie Veziant, Karine Poirot, Caroline Chevarin, Lucie Cassagnes, Pierre Sauvanet, Benoit Chassaing, Frederic Robin, Catherine Godfraind, Nicolas Barnich, Denis Pezet, Bruno Pereira, Johan Gagniere, Mathilde Bonnet. Prognostic value of a combination of innovative factors (gut microbiota, sarcopenia, obesity, metabolic syndrome) to predict surgical/oncologic outcomes following surgery for sporadic colorectal cancer: a prospective cohort study protocol (METABIOTE). BMJ Open 2020; 10(1): e031472 doi: 10.1136/bmjopen-2019-031472
|
145 |
Alicia Elena Rojas de Atencio. Metilación de genes supresores tumorales en cáncer colorrectal: relación con estadío clínico de la enfermedad. Revista Colombiana de Gastroenterología 2019; 34(1): 1 doi: 10.22516/25007440.225
|
146 |
Andre Luiz Prezotto Villa, Rogério Serafim Parra, Marley Ribeiro Feitosa, Hugo Parra de Camargo, Vanessa Foresto Machado, Daniela Pretti da Cunha Tirapelli, José Joaquim Ribeiro da Rocha, Omar Feres. PPARG expression in colorectal cancer and its association with staging and clinical evolution. Acta Cirúrgica Brasileira 2020; 35(7) doi: 10.1590/s0102-865020200070000008
|
147 |
Ulrich-Axel Bommer, Kara L. Vine, Prianka Puri, Martin Engel, Lisa Belfiore, Karen Fildes, Marijka Batterham, Alistair Lochhead, Morteza Aghmesheh. Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin. Cell Communication and Signaling 2017; 15(1) doi: 10.1186/s12964-017-0164-3
|
148 |
HJ Li, YL Wang, L Ming, XQ Guo, YL Li, JC Wang, YQ Zhang, L Cheng. Development of a prognostic model based on an immunogenomic landscape analysis of colorectal cancer. Future Oncology 2021; 17(3): 301 doi: 10.2217/fon-2020-0022
|
149 |
Marina Alorda-Clara, Margalida Torrens-Mas, Pere Miquel Morla-Barcelo, Toni Martinez-Bernabe, Jorge Sastre-Serra, Pilar Roca, Daniel Gabriel Pons, Jordi Oliver, Jose Reyes. Use of Omics Technologies for the Detection of Colorectal Cancer Biomarkers. Cancers 2022; 14(3): 817 doi: 10.3390/cancers14030817
|
150 |
Andrea G. Izquierdo, Paula M. Lorenzo, Ana B. Crujeiras. Epigenetics in Precision Medicine. 2022; : 327 doi: 10.1016/B978-0-12-823008-4.00012-3
|
151 |
Saleheh Rezapour, Elham Hosseinzadeh, Faroogh Marofi, Ali Hassanzadeh. Epigenetic‐based therapy for colorectal cancer: Prospect and involved mechanisms. Journal of Cellular Physiology 2019; 234(11): 19366 doi: 10.1002/jcp.28658
|
152 |
Aitor Rodríguez-Casanova, Aida Bao-Caamano, Ramón M. Lago-Lestón, Elena Brozos-Vázquez, Nicolás Costa-Fraga, Isabel Ferreirós-Vidal, Ihab Abdulkader, Yolanda Vidal-Insua, Francisca Vázquez Rivera, Sonia Candamio Folgar, Rafael López-López, Laura Muinelo-Romay, Angel Diaz-Lagares. Evaluation of a Targeted Next-Generation Sequencing Panel for the Non-Invasive Detection of Variants in Circulating DNA of Colorectal Cancer. Journal of Clinical Medicine 2021; 10(19): 4487 doi: 10.3390/jcm10194487
|
153 |
Elisa Marabotto, Stefano Kayali, Silvia Buccilli, Francesca Levo, Giorgia Bodini, Edoardo G. Giannini, Vincenzo Savarino, Edoardo Vincenzo Savarino. Colorectal Cancer in Inflammatory Bowel Diseases: Epidemiology and Prevention: A Review. Cancers 2022; 14(17): 4254 doi: 10.3390/cancers14174254
|
154 |
Xiaonuan Luo, Shanshan Chang, Siyu Xiao, Yin Peng, Yuli Gao, Fan Hu, Jianxue Liang, Yidan Xu, Kaining Du, Yang Chen, Jiequan Qin, Stephen J. Meltzer, Shiqi Deng, Xianling Feng, Xinmin Fan, Gangqiang Hou, Zhe Jin, Xiaojing Zhang. PAD4-dependent citrullination of nuclear translocation of GSK3β promotes colorectal cancer progression via the degradation of nuclear CDKN1A. Neoplasia 2022; 33: 100835 doi: 10.1016/j.neo.2022.100835
|
155 |
Mohsin Saeed, Hadi M. Marwani, Umer Shahzad, Abdullah M. Asiri, Mohammed M. Rahman. Recent Advances, Challenges, and Future Perspectives of ZnO Nanostructure Materials Towards Energy Applications. The Chemical Record 2023; doi: 10.1002/tcr.202300106
|
156 |
Lilang Lv, Bowen Xin, Yichao Hao, Ziyi Yang, Junyan Xu, Lisheng Wang, Xiuying Wang, Shaoli Song, Xiaomao Guo. Radiomic analysis for predicting prognosis of colorectal cancer from preoperative 18F-FDG PET/CT. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03262-5
|
157 |
Inês P. Santos, Elisa M. Barroso, Tom C. Bakker Schut, Peter J. Caspers, Cornelia G. F. van Lanschot, Da-Hye Choi, Martine F. van der Kamp, Roeland W. H. Smits, Remco van Doorn, Rob M. Verdijk, Vincent Noordhoek Hegt, Jan H. von der Thüsen, Carolien H. M. van Deurzen, Linetta B. Koppert, Geert J. L. H. van Leenders, Patricia C. Ewing-Graham, Helena C. van Doorn, Clemens M. F. Dirven, Martijn B. Busstra, Jose Hardillo, Aniel Sewnaik, Ivo ten Hove, Hetty Mast, Dominiek A. Monserez, Cees Meeuwis, Tamar Nijsten, Eppo B. Wolvius, Robert J. Baatenburg de Jong, Gerwin J. Puppels, Senada Koljenović. Raman spectroscopy for cancer detection and cancer surgery guidance: translation to the clinics. The Analyst 2017; 142(17): 3025 doi: 10.1039/C7AN00957G
|
158 |
Jieun Choo, Gwangbeom Heo, Charalabos Pothoulakis, Eunok Im. Posttranslational modifications as therapeutic targets for intestinal disorders. Pharmacological Research 2021; 165: 105412 doi: 10.1016/j.phrs.2020.105412
|
159 |
Chengsheng Ding, Zezhi Shan, Mengcheng Li, Yang Xia, Zhiming Jin. Exploration of the Associations of lncRNA Expression Patterns with Tumor Mutation Burden and Prognosis in Colon Cancer. OncoTargets and Therapy 2021; : 2893 doi: 10.2147/OTT.S300095
|
160 |
Kaisa Lehtomäki, Harri Mustonen, Pirkko-Liisa Kellokumpu-Lehtinen, Heikki Joensuu, Kethe Hermunen, Leena-Maija Soveri, Mogens Karsbøl Boisen, Christian Dehlendorff, Julia Sidenius Johansen, Caj Haglund, Pia Osterlund. Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer. Cancers 2021; 13(15): 3892 doi: 10.3390/cancers13153892
|
161 |
Xiao Xie, Huajiang Lin, Xiaolei Zhang, Pengtao Song, Xiangyi He, Jing Zhong, Jiemin Shi. Overexpression of GDP dissociation inhibitor 1 gene associates with the invasiveness and poor outcomes of colorectal cancer. Bioengineered 2021; 12(1): 5595 doi: 10.1080/21655979.2021.1967031
|
162 |
Jana Maslankova, Ivana Vecurkovska, Miroslava Rabajdova, Jana Katuchova, Milos Kicka, Michala Gayova, Vladimir Katuch. Regulation of transforming growth factor-β signaling as a therapeutic approach to treating colorectal cancer. World Journal of Gastroenterology 2022; 28(33): 4744-4761 doi: 10.3748/wjg.v28.i33.4744
|
163 |
Fenghai Ren, Baojun Li, Chao Wang, Yanbo Wang, Binbin Cui. Iodine-125 seed represses the growth and facilitates the apoptosis of colorectal cancer cells by suppressing the methylation of miR-615 promoter. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-021-09141-4
|
164 |
Qian Kang, Xin Guo, Tianfu Li, Caiqin Yang, Jingwan Han, Lei Jia, Yongjian Liu, Xiaolin Wang, Bohan Zhang, Jingyun Li, Hong-Ling Wen, Hanping Li, Lin Li. Identification of differentially expressed HERV-K(HML-2) loci in colorectal cancer. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1192900
|
165 |
Dingling Li, Wenxing Gao, Wen Zhao, Yingjie Zhao, Yanfei Zhang, Ying Liu, Yuying Li, Shuaifei Ji, Peng Chen, Dingchang Li. Molecular subtypes identified by multiomics analysis based on cuproptosis‑related genes precisely predict response to immunotherapy and chemotherapy in colorectal cancer. Molecular Carcinogenesis 2023; 62(11): 1755 doi: 10.1002/mc.23613
|
166 |
Enkui Zhang, Xueliang Zhou, Xiaodong Fan, Shuchun Li, Chengsheng Ding, Hiju Hong, Batuer Aikemu, Guang Yang, Galiya Yesseyeva, Xiao Yang, Junjun Ma, Minhua Zheng. Exploring the relationship between lactate metabolism and immunological function in colorectal cancer through genes identification and analysis. Frontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1173803
|
167 |
Jun Wang, Shaojun Yu, Guofeng Chen, Muxing Kang, Xiaoli Jin, Yi Huang, Lele Lin, Dan Wu, Lie Wang, Jian Chen. A novel prognostic signature of immune‐related genes for patients with colorectal cancer. Journal of Cellular and Molecular Medicine 2020; 24(15): 8491 doi: 10.1111/jcmm.15443
|
168 |
Sayed Mostafa Hosseini, Frouzandeh Mahjoubi, Tayebeh Majidzadeh, Fattaneh Khaje-Hosseini, Mahya Haghipanah. Nebulette Expression Is Associated with Lymph Node Metastasis in Patients with Colorectal Cancer. Middle East Journal of Digestive Diseases 2018; 10(3): 174 doi: 10.15171/mejdd.2018.107
|
169 |
Fatemeh Abbaszadeh, Sajad Fakhri, Sana Piri, Haroon Khan. Phytonutrients in the Treatment of Gastrointestinal Cancer. 2023; : 1 doi: 10.2174/9789815049633123010004
|
170 |
Feng Wang, Jun Wang, Xiangyu Cao, Lihui Xu, Lin Chen. Hsa_circ_0014717 is downregulated in colorectal cancer and inhibits tumor growth by promoting p16 expression. Biomedicine & Pharmacotherapy 2018; 98: 775 doi: 10.1016/j.biopha.2018.01.015
|
171 |
David Ortiz-López, Joaquín Marchena-Gómez, Eva Nogués-Ramía, Yurena Sosa-Quesada, Beatriz Arencibia-Pérez, Manuel Artiles-Armas, Cristina Roque-Castellano. Utility of a new prognostic score based on the Comprehensive Complication Index (CCI®) in patients operated on for colorectal cancer (S-CRC-PC score). Surgical Oncology 2022; 42: 101780 doi: 10.1016/j.suronc.2022.101780
|
172 |
Sujata Pathak, Asrar Alam. Toxicology and Human Health. 2023; : 179 doi: 10.1007/978-981-99-2193-5_8
|
173 |
Mohammad Reza Mohammad Hoseini Azar, Hamed Aghazadeh, Halgurd Nadhim Mohammed, Mehdi Rezai Seghin Sara, Arezoo Hosseini, Navid Shomali, Rozita Tamjidifar, Saeed Tarzi, Mahmoud Mansouri, Sahar Pashaei Sarand, Faroogh Marofi, Morteza Akbari, Huaxi Xu, Siamak Sandoghchian Shotorbani. miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4. International Immunopharmacology 2021; 92: 107355 doi: 10.1016/j.intimp.2020.107355
|
174 |
Jinghu He, Xiaohong Yang, Chuansen Zhang, Ang Li, Wei Wang, Junjie Xing, Jifu E, Xiaodong Xu, Hao Wang, Enda Yu, Debing Shi, Hantao Wang. CNN2 silencing inhibits colorectal cancer development through promoting ubiquitination of EGR1. Life Science Alliance 2023; 6(7): e202201639 doi: 10.26508/lsa.202201639
|
175 |
Margherita Binetti, Augusto Lauro, Samuele Vaccari, Maurizio Cervellera, Valeria Tonini. Proteogenomic biomarkers in colorectal cancers: clinical applications. Expert Review of Proteomics 2020; 17(5): 355 doi: 10.1080/14789450.2020.1782202
|
176 |
Tomasz Sawicki, Monika Ruszkowska, Anna Danielewicz, Ewa Niedźwiedzka, Tomasz Arłukowicz, Katarzyna E. Przybyłowicz. A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis. Cancers 2021; 13(9): 2025 doi: 10.3390/cancers13092025
|
177 |
Caroline H. Johnson, Jaya Prakash Golla, Evangelos Dioletis, Surendra Singh, Momoko Ishii, Georgia Charkoftaki, David C. Thompson, Vasilis Vasiliou. Molecular Mechanisms of Alcohol-Induced Colorectal Carcinogenesis. Cancers 2021; 13(17): 4404 doi: 10.3390/cancers13174404
|
178 |
Xun Zhao, Dejun Cui, Fang Yan, Liuchan Yang, Bo Huang. Circ_0007919 exerts an anti-tumor role in colorectal cancer through targeting miR-942–5p/TET1 axis. Pathology - Research and Practice 2022; 229: 153704 doi: 10.1016/j.prp.2021.153704
|
179 |
Tonje Bjørnetrø, Kathrine Røe Redalen, Sebastian Meltzer, Nirujah Sivarajah Thusyanthan, Rampradeep Samiappan, Caroline Jegerschöld, Karianne Risberg Handeland, Anne Hansen Ree. An experimental strategy unveiling exosomal microRNAs 486‐5p, 181a‐5p and 30d‐5p from hypoxic tumour cells as circulating indicators of high‐risk rectal cancer. Journal of Extracellular Vesicles 2019; 8(1) doi: 10.1080/20013078.2019.1567219
|
180 |
Ya-Fei Qin, Guang-Ming Li, Grace Wang, De-Jun Kong, Hong-Da Wang, Yi-Ming Zhao, Jing-Peng Hao, Hong Qin, Da-Qing Sun, Hao Wang. Identification of Hub Gene TIMP1 and Relative ceRNAs Regulatory Network in Colorectal Cancer. Therapeutics and Clinical Risk Management 2021; : 889 doi: 10.2147/TCRM.S321101
|
181 |
Muriel X. G. Draht, Danny Goudkade, Alexander Koch, Heike I. Grabsch, Matty P. Weijenberg, Manon van Engeland, Veerle Melotte, Kim M. Smits. Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review. Clinical Epigenetics 2018; 10(1) doi: 10.1186/s13148-018-0461-8
|
182 |
Xiang-hao Xu, Wen Song, Jun-hua Li, Ze-qi Huang, Ya-fang Liu, Qiang Bao, Zhi-wen Shen. Long Non-coding RNA EBLN3P Regulates UHMK1 Expression by Sponging miR-323a-3p and Promotes Colorectal Cancer Progression. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.651600
|
183 |
Ehab Billatos, Fenghai Duan, Elizabeth Moses, Helga Marques, Irene Mahon, Lindsey Dymond, Charles Apgar, Denise Aberle, George Washko, Avrum Spira. Detection of early lung cancer among military personnel (DECAMP) consortium: study protocols. BMC Pulmonary Medicine 2019; 19(1) doi: 10.1186/s12890-019-0825-7
|
184 |
J. Deitrick, W.M. Pruitt. Molecular and Cellular Changes in the Cancer Cell. Progress in Molecular Biology and Translational Science 2016; 144: 49 doi: 10.1016/bs.pmbts.2016.09.010
|
185 |
J Theerthagiri, Sunitha Salla, R A Senthil, P Nithyadharseni, A Madankumar, Prabhakarn Arunachalam, T Maiyalagan, Hyun-Seok Kim. A review on ZnO nanostructured materials: energy, environmental and biological applications. Nanotechnology 2019; 30(39): 392001 doi: 10.1088/1361-6528/ab268a
|
186 |
Jiangmu Chen. Regulatory mechanism of RNA binding motif protein 15‐mediated N6 methyladenosine modification in proliferation, invasion, and migration of colorectal cancer cells. Environmental Toxicology 2023; 38(11): 2545 doi: 10.1002/tox.23883
|
187 |
Hyung-Hoon Oh, Young-Eun Joo. Novel biomarkers for the diagnosis and prognosis of colorectal cancer. Intestinal Research 2020; 18(2): 168 doi: 10.5217/ir.2019.00080
|
188 |
Sujani M. K. Gamage, Chamath D. Ranaweera, Tracie T. Cheng, Sharmin Aktar, Vinod Gopalan, Farhadul Islam. Current Cancer Biomarkers. 2023; : 11 doi: 10.2174/9789815079364123010005
|
189 |
Meera Nair, Sardul Singh Sandhu, Anil Kumar Sharma. Cancer molecular markers: A guide to cancer detection and management. Seminars in Cancer Biology 2018; 52: 39 doi: 10.1016/j.semcancer.2018.02.002
|
190 |
Hengzhou Zhu, Yi Ji, Wenting Li, Mianhua Wu. Identification of key pathways and genes in colorectal cancer to predict the prognosis based on mRNA interaction network. Oncology Letters 2019; doi: 10.3892/ol.2019.10698
|
191 |
Nurul-Syakima Ab Mutalib, Rashidah Baharuddin, Rahman Jamal. Computational Epigenetics and Diseases. 2019; : 289 doi: 10.1016/B978-0-12-814513-5.00018-0
|
192 |
Antioxidant Barrier, Redox Status, and Oxidative Damage to Biomolecules in Patients with Colorectal Cancer. Can Malondialdehyde and Catalase Be Markers of Colorectal Cancer Advancement?. Biomolecules 2019; 9(10): 637 doi: 10.3390/biom9100637
|
193 |
Jingtian Liu, Zongyou Chen, Jianbin Xiang, Xiaodong Gu. MicroRNA-155 acts as a tumor suppressor in colorectal cancer by targeting CTHRC1 in�vitro. Oncology Letters 2018; doi: 10.3892/ol.2018.8069
|
194 |
S.M. Qaderi, H. Swartjes, J.A.E. Custers, J.H.W. de Wilt. Health care provider and patient preparedness for alternative colorectal cancer follow-up; a review. European Journal of Surgical Oncology 2020; 46(10): 1779 doi: 10.1016/j.ejso.2020.06.017
|
195 |
Hyun-Chul Kim, Junghwa Chang, Hannah S Lee, Ho Jeong Kwon. Mitochondrial UQCRB as a new molecular prognostic biomarker of human colorectal cancer. Experimental & Molecular Medicine 2017; 49(11): e391 doi: 10.1038/emm.2017.152
|
196 |
Bowen Liu, Na Zhao, Yuanshi Zhou, Yuxuan Lu, Wangming Chen, Ziyue Huang, Dongsheng Wang, Yi Xu, Judy Wai Ping Yam, Yunfu Cui. Circular RNA circ_ABCB10 in cancer. Clinica Chimica Acta 2021; 518: 93 doi: 10.1016/j.cca.2021.03.010
|
197 |
Lizhen Ye, Tingting Fan, Ying Qin, Cheng Qiu, Lulu Li, Mengmeng Dai, Yaoyao Zhou, Yan Chen, Yuyang Jiang. MicroRNA-455-3p accelerate malignant progression of tumor by targeting H2AFZ in colorectal cancer. Cell Cycle 2023; 22(7): 777 doi: 10.1080/15384101.2022.2154549
|
198 |
|
199 |
Christos Kontovounisios, Shengyang Qiu, Shahnawaz Rasheed, Ara Darzi, Paris Tekkis. The role of neurotensin as a novel biomarker in the endoscopic screening of high-risk population for developing colorectal neoplasia. Updates in Surgery 2017; 69(3): 397 doi: 10.1007/s13304-017-0464-6
|
200 |
Jing Xu, Yunxia Pan, Yanyan Liu, Sha Na, Hui Zhou, Lu Li, Fengyuan Chen, Hang Song. A review of anti-tumour effects of ginsenoside in gastrointestinal cancer. Journal of Pharmacy and Pharmacology 2021; 73(10): 1292 doi: 10.1093/jpp/rgab048
|
201 |
Anand Bharathan, V. Sitaram. GI Surgery Annual. GI Surgery Annual 2019; 25: 139 doi: 10.1007/978-981-13-3227-2_5
|
202 |
Yan Lu, Qiaohong Zhang, Longyi Zhang. CD4+ Memory Stem T Cell in Peripheral Blood: A Promising Immune Index for Early Screening and Auxiliary Diagnosis of Colorectal Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.701738
|
203 |
Jing Yu, Zhen He, Xiaowen He, Zhanhao Luo, Lei Lian, Baixing Wu, Ping Lan, Haitao Chen. Comprehensive Analysis of the Expression and Prognosis for MMPs in Human Colorectal Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.771099
|
204 |
Jianfeng Hong, Xindong Chen, Lingli Chen, Yigang Wang, Biao Huang, Hongming Fang. Clinical Value of Combined Detection of Serum sTim-3 and CEA or CA19-9 for Postoperative Recurrence of Colorectal Cancer Diagnosis. Cancer Management and Research 2023; : 563 doi: 10.2147/CMAR.S407930
|
205 |
Veronika Tupá, Slávka Drahošová, Marián Grendár, Marian Adamkov. Expression and association of carbonic anhydrase IX and cyclooxygenase-2 in colorectal cancer. Pathology - Research and Practice 2019; 215(4): 705 doi: 10.1016/j.prp.2019.01.012
|
206 |
O.I. Coleman, D. Haller. Colorectal Neoplasia and the Colorectal Microbiome. 2020; : 135 doi: 10.1016/B978-0-12-819672-4.00007-6
|
207 |
María Fernanda Rubio, María Cecilia Lira, Francisco Damián Rosa, Adrían Dario Sambresqui, María Cecilia Salazar Güemes, Mónica Alejandra Costas. RAC3 influences the chemoresistance of colon cancer cells through autophagy and apoptosis inhibition. Cancer Cell International 2017; 17(1) doi: 10.1186/s12935-017-0483-x
|
208 |
Susana Olmedillas-López, Dennis César Lévano-Linares, Carmen Laura Aúz Alexandre, Luz Vega-Clemente, Edurne León Sánchez, Alejandro Villagrasa, Jaime Ruíz-Tovar, Mariano García-Arranz, Damián García-Olmo. Detection of <i>KRAS</i> G12D in colorectal cancer stool by droplet digital PCR. World Journal of Gastroenterology 2017; 23(39): 7087-7097 doi: 10.3748/wjg.v23.i39.7087
|
209 |
Antonio Jesús Banegas-Luna, Jorge Peña-García, Adrian Iftene, Fiorella Guadagni, Patrizia Ferroni, Noemi Scarpato, Fabio Massimo Zanzotto, Andrés Bueno-Crespo, Horacio Pérez-Sánchez. Towards the Interpretability of Machine Learning Predictions for Medical Applications Targeting Personalised Therapies: A Cancer Case Survey. International Journal of Molecular Sciences 2021; 22(9): 4394 doi: 10.3390/ijms22094394
|
210 |
Alireza Sanati, Mahsa Jalali, Keyvan Raeissi, Fathallah Karimzadeh, Mahshid Kharaziha, Sahar Sadat Mahshid, Sara Mahshid. A review on recent advancements in electrochemical biosensing using carbonaceous nanomaterials. Microchimica Acta 2019; 186(12) doi: 10.1007/s00604-019-3854-2
|
211 |
Katherine G. Birmingham, Isaac E. Robinson, Erin E. Edwards, Susan N. Thomas. Photoconversion and chromatographic microfluidic system reveals differential cellular phenotypes of adhesion velocity versus persistence in shear flow. Lab on a Chip 2020; 20(4): 806 doi: 10.1039/C9LC00923J
|
212 |
Apurva Bonde, Daniel A. Smith, Elias Kikano, Jennifer M. Yoest, Sree H. Tirumani, Nikhil H. Ramaiya. Overview of serum and tissue markers in colorectal cancer: a primer for radiologists. Abdominal Radiology 2021; 46(12): 5521 doi: 10.1007/s00261-021-03243-0
|
213 |
Chia-Cheng Lee, Yu-Cheng Kuo, Je-Ming Hu, Pi-Kai Chang, Chien-An Sun, Tsan Yang, Chuan-Wang Li, Chao-Yang Chen, Fu-Huang Lin, Chih-Hsiung Hsu, Yu-Ching Chou. <i>MTNR1B</i> polymorphisms with <i>CDKN2A</i> and <i>MGMT</i> methylation status are associated with poor prognosis of colorectal cancer in Taiwan. World Journal of Gastroenterology 2021; 27(34): 5737-5752 doi: 10.3748/wjg.v27.i34.5737
|
214 |
Xiaogai Li, Shihai Wang, HuiJun Ren, Junfen Ma, Xiaoxu Sun, Nan Li, Cailin Liu, Kaida Huang, Min Xu, Liang Ming. Molecular correlates and prognostic value of tmTNF-α expression in colorectal cancer of 5-Fluorouracil-Based Adjuvant Therapy. Cancer Biology & Therapy 2016; 17(6): 684 doi: 10.1080/15384047.2016.1187551
|
215 |
Nesreen H. Hafez, Noha Ezzat. Epidermal growth factor receptor expression in colorectal adenocarcinoma and their corresponding metastatic sites. Egyptian Journal of Pathology 2017; 37(2): 244 doi: 10.1097/01.XEJ.0000526543.24249.1
|
216 |
Camille Boulagnon-Rombi, Christophe Schneider, Chloé Leandri, Albin Jeanne, Virginie Grybek, Aude Marchal Bressenot, Coralie Barbe, Benjamin Marquet, Saviz Nasri, Christelle Coquelet, Caroline Fichel, Nicole Bouland, Arnaud Bonnomet, Reza Kianmanesh, Anne-Sophie Lebre, Olivier Bouché, Marie-Danièle Diebold, Georges Bellon, Stéphane Dedieu. LRP1 expression in colon cancer predicts clinical outcome. Oncotarget 2018; 9(10): 8849 doi: 10.18632/oncotarget.24225
|
217 |
Wenwen Xiang, Qiuxiang Lv, Haixia Shi, Bing Xie, Li Gao. Aptamer-based biosensor for detecting carcinoembryonic antigen. Talanta 2020; 214: 120716 doi: 10.1016/j.talanta.2020.120716
|
218 |
Usman Nasrullah, Kristina Stanke, Victoria Recknagel, Süleyman Bozkurt, Patrick Wurzel, Stefan Gauer, Gergely Imre, Christian Münch, Josef Pfeilschifter, Wolfgang Eberhardt. The E3 Ligase TRIM25 Impairs Apoptotic Cell Death in Colon Carcinoma Cells via Destabilization of Caspase-7 mRNA: A Possible Role of hnRNPH1. Cells 2023; 12(1): 201 doi: 10.3390/cells12010201
|
219 |
Hao Chen, Qinqin Qi, Nan Wu, Ying Wang, Qian Feng, Rong Jin, Lei Jiang. Aspirin promotes RSL3-induced ferroptosis by suppressing mTOR/SREBP-1/SCD1-mediated lipogenesis in PIK3CA-mutant colorectal cancer. Redox Biology 2022; 55: 102426 doi: 10.1016/j.redox.2022.102426
|
220 |
Peter McAnena, James Brown, Michael Kerin. Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer. Cancers 2017; 9(12): 5 doi: 10.3390/cancers9010005
|
221 |
John Thomas Palathingal, Basil Sunny, Vismaya Vijayan. Combining Chemotherapy with Immunotherapy in Colorectal Cancer: A Review. Clinical Cancer Drugs 2021; 8(1): 10 doi: 10.2174/2212697X07999201029200025
|
222 |
Xiaolin Hou, Nengyi Hou, Junwen Fu, Xuelai He, Haibo Xiong, Wei Xie, Guiqing Jia, Xiaofei Zuo, Xianpeng Qin, Minghui Pang. Identification of Key mRNAs and Pathways in Colorectal Cancer. Nutrition and Cancer 2021; 73(6): 1040 doi: 10.1080/01635581.2020.1783328
|
223 |
Jie Zhu, Weikaixin Kong, Zhengwei Xie. Expression and Prognostic Characteristics of Ferroptosis-Related Genes in Colon Cancer. International Journal of Molecular Sciences 2021; 22(11): 5652 doi: 10.3390/ijms22115652
|
224 |
Pourya Sarvari, Pouya Sarvari, Ivonne Ramírez-Díaz, Frouzandeh Mahjoubi, Karla Rubio. Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer. International Journal of Molecular Sciences 2022; 23(17): 9521 doi: 10.3390/ijms23179521
|
225 |
Jianxian Zhang, Yan Xue, Hengling Gao, Yunxi Yu, Huabin Cheng, Xukun Lv, Ke Ke, Yingbin Shen. circZC3HAV1 Regulates TBC1D9 to Affect the Biological Behavior of Colorectal Cancer Cells. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/7386946
|
226 |
Liping Guan, Yuanyuan Tang, Guanghua Li, Zhao Qin, Shaoshan Li. Comprehensive Analysis of Role of Cyclin-Dependent Kinases Family Members in Colorectal Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.921710
|
227 |
Florian Posch, Karina Silina, Sebastian Leibl, Axel Mündlein, Holger Moch, Alexander Siebenhüner, Panagiotis Samaras, Jakob Riedl, Michael Stotz, Joanna Szkandera, Herbert Stöger, Martin Pichler, Roger Stupp, Maries van den Broek, Peter Schraml, Armin Gerger, Ulf Petrausch, Thomas Winder. Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer. OncoImmunology 2018; 7(2) doi: 10.1080/2162402X.2017.1378844
|
228 |
Lanlan Xi, Quanlin Liu, Wei Zhang, Linshan Luo, Jingfeng Song, Ruitao Liu, Shue Wei, Yong Wang. Circular RNA circCSPP1 knockdown attenuates doxorubicin resistance and suppresses tumor progression of colorectal cancer via miR-944/FZD7 axis. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01855-6
|
229 |
Huan Zhang, Fan Lin, Zhuocai Wang. Mean platelet volume/platelet count ratio in combination with tumor markers in colorectal cancer: a retrospective clinical study. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10585-z
|
230 |
Simon Manuel Tria, Matthew E. Burge, Vicki L. J. Whitehall. The Therapeutic Landscape for KRAS-Mutated Colorectal Cancers. Cancers 2023; 15(8): 2375 doi: 10.3390/cancers15082375
|
231 |
Yujie Zhao, Wenjie Ma, Shanzi Zou, Biao Chen, Hong Cheng, Xiaoxiao He, Kemin Wang. Terminal deoxynucleotidyl transferase-initiated molecule beacons arrayed aptamer probe for sensitive detection of metastatic colorectal cancer cells. Talanta 2019; 202: 152 doi: 10.1016/j.talanta.2019.04.065
|
232 |
Eleonora Lai, Andrea Pretta, Valentino Impera, Stefano Mariani, Riccardo Giampieri, Laura Casula, Valeria Pusceddu, Pierpaolo Coni, Daniela Fanni, Marco Puzzoni, Laura Demurtas, Pina Ziranu, Gavino Faa, Mario Scartozzi. BRAF-mutant colorectal cancer, a different breed evolving. Expert Review of Molecular Diagnostics 2018; 18(6): 499 doi: 10.1080/14737159.2018.1470928
|
233 |
Ana Montero-Calle, Itziar Aranguren-Abeigon, María Garranzo-Asensio, Carmen Poves, María Jesús Fernández-Aceñero, Javier Martínez-Useros, Rodrigo Sanz, Jana Dziaková, Javier Rodriguez-Cobos, Guillermo Solís-Fernández, Eloy Povedano, Maria Gamella, Rebeca Magnolia Torrente-Rodríguez, Miren Alonso-Navarro, Vivian de los Ríos, J. Ignacio Casal, Gemma Domínguez, Ana Guzman-Aranguez, Alberto Peláez-García, José Manuel Pingarrón, Susana Campuzano, Rodrigo Barderas. Multiplexed Biosensing Diagnostic Platforms Detecting Autoantibodies to Tumor-Associated Antigens from Exosomes Released by CRC Cells and Tissue Samples Showed High Diagnostic Ability for Colorectal Cancer. Engineering 2021; 7(10): 1393 doi: 10.1016/j.eng.2021.04.026
|
234 |
Stefan Buettner, Boris Galjart, Jeroen L. A. van Vugt, Fabio Bagante, Sorin Alexandrescu, Hugo P. Marques, Jorge Lamelas, Luca Aldrighetti, T. Clark Gamblin, Shishir K. Maithel, Carlo Pulitano, Georgios A. Margonis, Matthew Weiss, Todd W. Bauer, Feng Shen, George A. Poultsides, J. Wallis Marsh, Jan N. M. IJzermans, Bas Groot Koerkamp, Timothy M. Pawlik. Performance of prognostic scores and staging systems in predicting long‐term survival outcomes after surgery for intrahepatic cholangiocarcinoma. Journal of Surgical Oncology 2017; 116(8): 1085 doi: 10.1002/jso.24759
|
235 |
Violetta Rosiek, Ksenia Janas, Magdalena Witkowska, Beata Kos-Kudła. Role of Selected Circulating Tumor Biomarkers in Patients with Skeletal Metastatic Pancreatic Neuroendocrine Neoplasms. Journal of Clinical Medicine 2023; 12(14): 4687 doi: 10.3390/jcm12144687
|
236 |
Stefan Buettner, Gaya Spolverato, Charles W. Kimbrough, Sorin Alexandrescu, Hugo P. Marques, Jorge Lamelas, Luca Aldrighetti, T. Clark Gamblin, Shishir K. Maithel, Carlo Pulitano, Matthew Weiss, Todd W. Bauer, Feng Shen, George A. Poultsides, J. Wallis Marsh, Jan N.M. IJzermans, Bas Groot Koerkamp, Timothy M. Pawlik. The impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio among patients with intrahepatic cholangiocarcinoma. Surgery 2018; 164(3): 411 doi: 10.1016/j.surg.2018.05.002
|
237 |
Ning An, Yaqin Zhao, Haitao Lan, Ming Zhang, Yuan Yin, Cheng Yi. SEZ6L2 knockdown impairs tumour growth by promoting caspase‐dependent apoptosis in colorectal cancer. Journal of Cellular and Molecular Medicine 2020; 24(7): 4223 doi: 10.1111/jcmm.15082
|
238 |
Yichao Liang, Qi Su, Xin Wu. Identification and Validation of a Novel Six-Gene Prognostic Signature of Stem Cell Characteristic in Colon Cancer. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.571655
|
239 |
A new biomarker of colorectal cancer patient after chemotherapy. 2ND INTERNATIONAL CONFERENCE ON EMERGING SMART MATERIALS IN APPLIED CHEMISTRY (ESMAC-2021): ESMAC-2021 2023; 2740: 030004 doi: 10.1063/5.0110048
|
240 |
D.S. Bhullar, J. Barriuso, S. Mullamitha, M.P. Saunders, S.T. O'Dwyer, O. Aziz. Biomarker concordance between primary colorectal cancer and its metastases. EBioMedicine 2019; 40: 363 doi: 10.1016/j.ebiom.2019.01.050
|
241 |
Ping Li, Zhongpei Weng, Pengfei Li, Fangyong Hu, Yan Zhang, Zijian Guo, Weibo Shen, Changyong Zhao, Saimin Dai. BATF3 promotes malignant phenotype of colorectal cancer through the S1PR1/p-STAT3/miR-155-3p/WDR82 axis. Cancer Gene Therapy 2021; 28(5): 400 doi: 10.1038/s41417-020-00223-2
|
242 |
Robin Mjelle, Kjersti Sellæg, Pål Sætrom, Liv Thommesen, Wenche Sjursen, Eva Hofsli. Identification of metastasis-associated microRNAs in serum from rectal cancer patients. Oncotarget 2017; 8(52): 90077 doi: 10.18632/oncotarget.21412
|